跳至主要内容
临床试验/JPRN-UMIN000053018
JPRN-UMIN000053018尚未招募Unknown

Cognitive Behavioral Therapy as an Intervention to Prevent Weight Rebound post Semaglutide Discontinuation - REBOUND-STOP

kansai medical university0 个研究点目标入组 40 人开始时间: 2024年1月1日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who fall under any of the following will not be included in this study. 1) Patients with severe hepatic or renal dysfunction 2) Pregnant and lactating women 3) Patients with malignant tumor 4) Patients with severe heart failure/arrhythmia 5) Patients with secondary obesity due to endocrine (hormone) or other drugs, etc. 6) Patients with a history of hypersensitivity to semaglutide 7) Patients with diabetic ketoacidosis, diabetic coma or precoma, type 1 diabetes 8) Severe infections in patients with type 2 diabetes, conditions requiring emergency surgery, etc. 9) Other patients deemed unsuitable as research subjects by the research director

研究者

相似试验